MF · holdings as filed 2026-03-31

What's inside BBH?

VanEck Biotech ETF
Holdings
25
positions in the fund
Top 10
71%
of fund assets
Expense ratio
0.35%
net, per year
Fund size
$372M
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
G
GILDGILEAD SCIENCES INC
14.61%
2
A
AMGNAMGEN INC
14.52%
3
V
VRTXVERTEX PHARMACEUTICALS INC
8.05%
4
R
REGNREGENERON PHARMACEUTICALS
7.50%
5
A
ARGXARGENX SE - ADR
5.27%
6
I
INSMINSMED INC
4.58%
7
A
ALNYALNYLAM PHARMACEUTICALS INC
4.10%
8
N
NTRANATERA INC
3.97%
9
U
UTHRUNITED THERAPEUTICS CORP
3.80%
10
B
BIIBBIOGEN INC
3.72%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
G
GILDGILEAD SCIENCES INC
14.61%
2
A
AMGNAMGEN INC
14.52%
3
V
VRTXVERTEX PHARMACEUTICALS INC
8.05%
4
R
REGNREGENERON PHARMACEUTICALS
7.50%
5
I
INSMINSMED INC
4.58%
6
I
IQVIQVIA HOLDINGS INC
4.29%
7
A
ALNYALNYLAM PHARMACEUTICALS INC
4.10%
8
N
NTRANATERA INC
3.97%
9
U
UTHRUNITED THERAPEUTICS CORP
3.80%
10
B
BIIBBIOGEN INC
3.72%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold BBH alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-03-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.